Research any topic before you write.

Find related topics. | Discover entities. | See connections. | Build a topical map.

Intercell: History, Companies, Technology & Products

Intercell AG was a biotechnology company based in Vienna which focused on the development of modern prophylactic and therapeutic vaccines against infectious diseases. The company merged with Vivalis to form Valneva SE in 2012. Intercell was formed in 1998 as a spin-off of the Research Institute of Molecular Pathology (IMP) in Vienna. It employs 400…

Language: English [EN]
Use the mouse wheel or two fingers (on touchscreens) to zoom in and out of the map.
100%
More settings
100% 100% 100% 100% 100%

Intercell topic overview

The analysis highlights History, Companies, Technology and Products as prominent areas in the source structure around Intercell.

Related topics
20
Source areas
2
Connected nodes
22
Extracted relationships
28
Concept neighborhoods
13
Bridge connections
22

What this topic covers Research coverage

Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.

History · 15 topics
Overview · 5 topics

Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.

Key facts & relationships

High-confidence facts extracted from structured source data. Use them as anchors for further research.

Founded
1998
Industry
Biotechnology
Headquarters
Vienna, Austria
Defunct
2013 (2013)
Fate
Merged with Vivalis SA
Key people
Thomas Lingelbach (CEO), Michel Gréco (Chairman of the supervisory board)

Explore all related topics Closing gaps

Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.

Overview

History

Advanced semantic analysis

Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.

How Intercell connects Entity context

The extracted context around Intercell shows recurring relationship patterns in the source. For example, Intercell → February, French, In, Intercell AG, Intercell AG's, It, Japanese, Maryland-based Iomai, Valneva, Vienna Stock Exchange, Vivalis SE Another extracted example is Intercell → 2013 (2013). Use these groups to spot repeated connection types before inspecting the individual relationships.

Intercell

Top relations

related to history · 11
Intercell → February, French, In, Intercell AG, Intercell AG's, It, Japanese, Maryland-based Iomai, Valneva, Vienna Stock Exchange, Vivalis SE
Defunct · 1
Intercell → 2013 (2013)
Fate · 1
Intercell → Merged with Vivalis SA
Founded · 1
Intercell → 1998
Headquarters · 1
Intercell → Vienna, Austria
Industry · 1
Intercell → Biotechnology
Key people · 1
Intercell → Thomas Lingelbach (CEO), Michel Gréco (Chairman of the supervisory board)
Net income · 1
Intercell → (€255.2 million) (2010)
Number of employees · 1
Intercell → 410 (average, 2010)
Operating income · 1
Intercell → (€251.2 million) (2010)

Important terminology

Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.

Important terminology

vienna valneva company vaccines ag development merged vivalis se biotechnology austria products people vaccine focused therapeutic infectious diseases form 2012

Intercell relationships Subject–Predicate–Object triples

TTTA extracted 28 structured relationships around Intercell. Examples in this analysis include Intercell → Defunct → 2013 (2013) and Intercell → Fate → Merged with Vivalis SA. The table shows each extracted connection, where it came from and its confidence.

SubjectPredicateObjectConfidenceSrc
IntercellDefunct2013 (2013)1.00infobox
IntercellFateMerged with Vivalis SA1.00infobox
IntercellFounded19981.00infobox
IntercellHeadquartersVienna, Austria1.00infobox
IntercellIndustryBiotechnology1.00infobox
IntercellKey peopleThomas Lingelbach (CEO), Michel Gréco (Chairman of the supervisory board)1.00infobox
IntercellNet income(€255.2 million) (2010)1.00infobox
IntercellNumber of employees410 (average, 2010)1.00infobox
IntercellOperating income(€251.2 million) (2010)1.00infobox
IntercellProductsDevelopment of vaccines1.00infobox
IntercellRevenue€34.2 million (2010)1.00infobox
IntercellSuccessorValneva SE1.00infobox
IntercellTotal assets€225.2 million (end 2010)1.00infobox
IntercellTotal equity€121.1 million (end 2010)1.00infobox
IntercellTraded asWBAG: ICLL OTCQX: INRLY1.00infobox
IntercellTypeAktiengesellschaft1.00infobox
IntercellWebsitewww.intercell.com1.00infobox

Related concept clusters Concept neighborhoods

The concept neighborhoods around Intercell bring nearby vocabulary together. In this analysis, examples include Vienna, Development and Diseases. Use the clusters to find adjacent concepts and terminology that may deserve separate research.

  • Intercell
    • Vienna
    • Development
    • Diseases
    • Encephalitis
    • Focused
    • Hepatitis
    • Infectious
    • Japanese
    • Products
    • Research
    • Therapeutic
    • Vaccines
  • intercell
    • Vienna
    • Development
    • Diseases
    • Encephalitis
    • Focused
    • Hepatitis
    • Infectious
    • Japanese
    • Products
    • Research
    • Therapeutic
    • Vaccines
  • therapeutic vaccines
    • Founded
    • Vienna
    • Austria
    • Clinical
    • Encephalitis
    • Hepatitis
    • Ii
    • Japanese
    • People
    • Phase
    • Products
    • Research
  • research institute of molecular pathology
    • Molecular
    • Pathology
    • Spin-off
    • Founded
    • Research
    • Vienna
    • Austria
    • People
    • Products
    • Vaccines
    • Website
    • Se
  • valneva se
    • Se
    • Valneva
    • Vivalis
    • Founded
    • Austria
    • People
    • Products
    • Research
    • Vaccines
    • Website
    • Vienna
  • japanese encephalitis
    • Hepatitis
    • Japanese
    • Clinical
    • Ii
    • Infectious
    • Phase
    • Products
    • Therapeutic
    • Intercell
    • Vaccine
  • hepatitis c
    • Encephalitis
    • Japanese
    • Clinical
    • Ii
    • Infectious
    • Phase
    • Products
    • Therapeutic
    • Intercell
    • Vaccine
  • valneva
    • Se
    • Vivalis
    • Founded
    • Austria
    • People
    • Products
    • Research
    • Website
    • Vienna

Connections between topic areas Semantic bridges

For Intercell, one of the stronger structural bridges in this analysis connects Intercell with History. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.

Min side: 3
Intercell — History · splits 7 ⟂ 16
Intercell — Overview · splits 17 ⟂ 6

Map overview Semantic statistics

Intercell

Nodes23
Edges22
Triples28
Avg. degree1.91
Density0.086957
Components1

Source & methodology

TTTA analyzes the structure around Intercell to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as History, Companies, Technology & Products, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.

Source: Wikipedia — Intercell · EN edition · Analysis: TopicsToTalkAbout

For writers, content strategists, SEOs, marketers and creators — from quick topic research to advanced semantic analysis.